Based on a review of 3,495 echocardiographic studies to evaluate left ventricular ejection fraction (LVEF), researchers found that cardiologists changed initial artificial intelligence (AI) assessment 16.8 percent of the time and initial sonographer assessment 27.2 percent of the time.
Emerging research suggests that an artificial intelligence (AI) model is approximately 10 percent more accurate than sonographers at interpreting left ventricular ejection fraction (LVEF) on echocardiograms.
For the blinded, randomized trial, recently published in Nature, researchers compared initial sonographer assessment of echocardiograms for LEVF (1,755 studies) versus initial AI assessment (1,740 studies). According to the study, the AI model was trained with 144,184 echocardiogram videos from Stanford Healthcare. Twenty-five cardiac sonographers (with a mean of 14.1 years of experience in practice) reviewed the echocardiograms and 10 cardiologists (mean of 12.7 years of experience in practice) completed final reviews of the initial AI and sonographer assessments.
Cardiologists substantially changed 292 study assessments (16.8 percent) in the AI group and 478 interpretations (27.2 percent) in the sonographer group. Researchers also reported time savings for cardiologists reviewing AI findings, noting that cardiologists spent a median of 54 seconds to review initial AI assessment of LEVF on echocardiograms in comparison to a median of 64 seconds for review of sonographer findings.
“After blinded review of AI versus sonographer-guided LVEF assessment, cardiologists were less likely to substantially change the LVEF assessment for their final report with initial AI assessment. Furthermore, AI-guided assessment took less time for cardiologists to overread and was more consistent with cardiologist assessment from the previous clinical report,” wrote study co-author David Ouyang, M.D., who is affiliated with the Department of Cardiology at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at the Cedars-Sinai Medical Center in Los Angeles, and colleagues.
(Editor’s note: For related content, see “Pie Medical Imaging Launches AI-Powered Echocardiography Platform” and “FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.”)
The study authors also noted the majority of cardiologists could not tell the difference between initial AI and initial sonographer assessments with 43.4 percent being unsure and 24.2 percent guessing incorrectly about the source of the initial echocardiogram interpretation.
In addition to the inherent limitations of a single center study, the authors conceded their research was not powered for evaluation of long-term outcomes associated with differences in LVEF assessment. Noting that the study involved prospective evaluation of previously acquired echocardiogram studies, the researchers acknowledged a potential for bias when sonographers interpret images scanned by another sonographer.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.